0001225208-16-023457.txt : 20160105
0001225208-16-023457.hdr.sgml : 20160105
20160105161101
ACCESSION NUMBER: 0001225208-16-023457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160101
FILED AS OF DATE: 20160105
DATE AS OF CHANGE: 20160105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bose Supratim
CENTRAL INDEX KEY: 0001538431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 161322212
MAIL ADDRESS:
STREET 1: 11A COOLING CLOSE
CITY: SINGAPORE
STATE: U0
ZIP: 558176
4
1
doc4.xml
X0306
4
2016-01-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001538431
Bose Supratim
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & President, Asia-Pacific
Common Stock
2016-01-01
4
M
0
34302.0000
0.0000
A
150697.0000
D
Common Stock
2016-01-03
4
M
0
14926.0000
0.0000
A
165623.0000
D
Performance Share Units
2016-01-01
4
M
0
34302.0000
0.0000
D
2015-12-31
2015-12-31
Common Stock
34302.0000
0.0000
D
Deferred Stock Units
2016-01-03
4
M
0
14926.0000
0.0000
D
Common Stock
14926.0000
14926.0000
D
On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2015.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on January 3, 2013, the first anniversary of the date of grant.
/s/ Lee G. Giguere, Attorney-in-Fact
2016-01-05